November 5, 2026
Illuminating the Shadows: The Global Crusade to Turn Metastatic Breast Cancer Research into a Survivable Reality illuminating-the-shadows-the-global-crusade-to-turn-metastatic-breast-cancer-research-into-a-survivable-reality

Illuminating the Shadows: The Global Crusade to Turn Metastatic Breast Cancer Research into a Survivable Reality

Neng Nana October 16, 2026
NEW YORK, NY — As Breast Cancer Awareness Month blankets the world in varying shades of pink,...
Read More Read more about Illuminating the Shadows: The Global Crusade to Turn Metastatic Breast Cancer Research into a Survivable Reality
Precision De-escalation: CompassHER2-pCR Trial Signals a Paradigm Shift in HER2-Positive Breast Cancer Treatment precision-de-escalation-compassher2-pcr-trial-signals-a-paradigm-shift-in-her2-positive-breast-cancer-treatment

Precision De-escalation: CompassHER2-pCR Trial Signals a Paradigm Shift in HER2-Positive Breast Cancer Treatment

Asro October 16, 2026
For decades, the standard of care for aggressive breast cancer was defined by a "more is better"...
Read More Read more about Precision De-escalation: CompassHER2-pCR Trial Signals a Paradigm Shift in HER2-Positive Breast Cancer Treatment
University of Oklahoma Scientists Uncover Novel Mechanism: How Aggressive Breast Cancer Hijacks Immune System to Recruit Nerves, Fueling Growth university-of-oklahoma-scientists-uncover-novel-mechanism-how-aggressive-breast-cancer-hijacks-immune-system-to-recruit-nerves-fueling-growth

University of Oklahoma Scientists Uncover Novel Mechanism: How Aggressive Breast Cancer Hijacks Immune System to Recruit Nerves, Fueling Growth

Nila Kartika Wati October 15, 2026
NORMAN, OK – In a significant breakthrough that could reshape the future of cancer treatment, researchers at...
Read More Read more about University of Oklahoma Scientists Uncover Novel Mechanism: How Aggressive Breast Cancer Hijacks Immune System to Recruit Nerves, Fueling Growth
Verastem Oncology Gears Up for Pivotal Phase III Trials of Promising KRAS Inhibitor VS-7375 Following Compelling Data Readout verastem-oncology-gears-up-for-pivotal-phase-iii-trials-of-promising-kras-inhibitor-vs-7375-following-compelling-data-readout

Verastem Oncology Gears Up for Pivotal Phase III Trials of Promising KRAS Inhibitor VS-7375 Following Compelling Data Readout

Pevita Pearce October 15, 2026
Boston, MA – October 14, 2026 – Verastem Oncology (NASDAQ: VSTM) announced today a significant stride forward...
Read More Read more about Verastem Oncology Gears Up for Pivotal Phase III Trials of Promising KRAS Inhibitor VS-7375 Following Compelling Data Readout
Navigating the Intersection of GLP-1 Medications and Breast Cancer: A Comprehensive Overview navigating-the-intersection-of-glp-1-medications-and-breast-cancer-a-comprehensive-overview

Navigating the Intersection of GLP-1 Medications and Breast Cancer: A Comprehensive Overview

Nila Kartika Wati October 15, 2026
Introduction: A Growing Conversation In recent years, Glucagon-Like Peptide-1 (GLP-1) receptor agonists have surged into the medical...
Read More Read more about Navigating the Intersection of GLP-1 Medications and Breast Cancer: A Comprehensive Overview
Strengthening Global Health: WHO Director-General Highlights Jordan’s Role as a Humanitarian Beacon strengthening-global-health-who-director-general-highlights-jordans-role-as-a-humanitarian-beacon-4

Strengthening Global Health: WHO Director-General Highlights Jordan’s Role as a Humanitarian Beacon

Lina Hope October 15, 2026
Executive Summary: A Strategic Partnership The Director-General of the World Health Organization (WHO), Dr. Tedros Adhanom Ghebreyesus,...
Read More Read more about Strengthening Global Health: WHO Director-General Highlights Jordan’s Role as a Humanitarian Beacon
A New Chapter for Next-Gen Oncology: Armed Cell Therapeutics Acquires Lakefront Biotherapeutics’ CAR-T Portfolio a-new-chapter-for-next-gen-oncology-armed-cell-therapeutics-acquires-lakefront-biotherapeutics-car-t-portfolio

A New Chapter for Next-Gen Oncology: Armed Cell Therapeutics Acquires Lakefront Biotherapeutics’ CAR-T Portfolio

Suro Senen October 15, 2026
In a strategic maneuver that breathes new life into a discarded pipeline, the Belgian biotech landscape witnessed...
Read More Read more about A New Chapter for Next-Gen Oncology: Armed Cell Therapeutics Acquires Lakefront Biotherapeutics’ CAR-T Portfolio

You may have missed

groundbreaking-study-unveils-potent-triple-combination-therapy-offering-unprecedented-hope-against-aggressive-glioblastoma

Groundbreaking Study Unveils Potent Triple-Combination Therapy, Offering Unprecedented Hope Against Aggressive Glioblastoma

Nana Wu November 5, 2026
gan-lees-obesity-drug-maintains-weight-loss-in-phase-iii-trial

Gan & Lee’s obesity drug maintains weight loss in Phase III trial 

Suro Senen November 5, 2026
rekindling-intimacy-navigating-sexual-health-after-breast-cancer-treatment

Rekindling Intimacy: Navigating Sexual Health After Breast Cancer Treatment

Ali Ikhwan November 5, 2026
a-historic-victory-africa-declared-free-of-wild-poliovirus

A Historic Victory: Africa Declared Free of Wild Poliovirus

Ali Ikhwan November 5, 2026